Source: Annual Congress 2007 - Unravelling molecular mysteries of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Yoshida, L. Zhen, A. Richter, T. Rangasamy, R. Thimmulappa, S. Biswal, I. Petrache, S. Shapiro, I. Mett, E. Feinstein, R. Tuder (Baltimore, MD, Indianapolis, IN, Pittsburgh, PA, Fremont, CA, United States Of America). Lack of RTP801, a suppressor of the mTOR pathway, attenuates cigarette smoke-induced pulmonary injuries in mice. Eur Respir J 2007; 30: Suppl. 51, 922

Member's Comments

No comment yet.

Related content which might interest you: Mitochondria-targeted H2S suppresses and reverses cigarette smoke-induced inflammasome activity and lung injury in experimental COPD Source: ERS Lung Science Conference 2020 Year: 2020 TSC1/mTOR pathway promotes hypoxia-induced pulmonary hypertension in mice Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 A role of mTOR in cigarette smoke-induced corticosteroid insensitivity Source: Annual Congress 2012 - Cellular signalling mechanisms in the airways Year: 2012 Cigarette smoke upregulates IL-8/CXCL8 expression by augmenting mRNA stability via p38 MAPK/MK2 signalling in normal human pulmonary cells Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012 The AMPK-TSC1/2-mTOR signaling pathway regulates cigarette smoking-induced inflammation and apoptosis in airway epithelial cells Source: International Congress 2015 – Molecular pathways of lung injury due to tobacco-related products Year: 2015 Ablation of ADAM17 protects against cigarette smoke-induced emphysema in mice Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms Year: 2019 PDE4 inhibition prevents corticosteroid-resistant lung inflammation induced by cigarette smoke exposure in mice Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009 The role of microRNA-155 in cigarette smoke-induced inflammation. Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases Year: 2018 Disruption of pulmonary lipid homeostasis drives cigarette smoke-induced lung inflammation in mice Source: Eur Respir J 2015; 46: 1451-1460 Year: 2015 Cigarette smoke impairs Sirt1 activity and promotes pro-inflammatory responses in bronchial epithelial cells Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 RAGE blocking ameliorates cigarette smoke extract-induced human alveolar tpye II epithelial cell injury via RAGE-mediated redox sensitive DAMP signaling through Nrf2 Source: International Congress 2018 – COPD: immune regulation and therapeutic targets Year: 2018 Caspase-7 knockout mice are not protected against cigarette smoke-induced inflammation Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Quercetin attenuates inflammation in cigarette smoke stimulated airway epithelial cells: Possible involvement of autophagy Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 ERK MAP kinase is upregulated in pulmonary emphysema and mediates MMP-1 induction by cigarette smoke Source: Eur Respir J 2004; 24: Suppl. 48, 437s Year: 2004 Inhibition of NOX2 oxidase activity ameliorates cigarette smoke-induced lung inflammation and wasting in mice Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016 Ceramide-1-phosphate inhibits cigarette smoke-induced airway inflammation Source: Eur Respir J 2015; 45: 1669-1680 Year: 2015 Resveratrol attenuates cigarette smoke induced oxidative stress: Possible involvement of SIRT1 Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012 P2RX4 signalling enhances acute cigarette smoke-induced lung inflammation and chronic lung emphysema development Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 6-aminonicotinamide ameliorates pulmonary fibrosis by suppressing the TGF-beta1 activated Smad signalling pathway Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Role of aberrant Wnt signaling in the lung epithelial response to cigarette smoke in COPD Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011